|
Z.M. Safiullina, L.A. Salnikova, S.V. Shalaev
DURATION OF DUAL ANTIPLATELET THERAPY: DEBATABLE QUESTIONS AND POSSIBLE SOLUTIONS
|
8-12 |
|
Yu.E. Nesterov, N.N. Zavadenko
MODERN PRINCIPLES OF PROPHYLACTIC THERAPY OF MIGRAINE IN CHILDREN AND ADOLESCENTS
|
13-19 |
|
E.I. Astashkin
EFFECT OF HYPOXIA ON THE LIFE OF TUMOR CELLS AND ITS CORRECTION BY CHEMICAL AGENTS AND DRUGS
|
20-27 |
|
M.V. Pchelintsev
CERAXON (CITICOLINE) IN THE CONTEXT OF THE PROBLEM OF CHOICE BETWEEN ORIGINAL DRUGS AND GENERICS IN CLINICAL PRACTICE
|
28-33 |
|
R.S. Prokhorov, A.V. Kuligin, E.P. Matveeva, E.V. Kochetkova
INFLUENCE OF NEUROPROTECTIVE THERAPY WITH CELLEX ON COURSE OF ENCEPHALOPATHY IN CRITICALLY ILL PATIENTS
|
34-36 |
|
E.A. Kovalenko, A.N. Bogolepova
POST-STROKE COGNITIVE IMPAIRMENT: NEW PERSPECTIVES FOR NEUROPROTECTION
|
37-42 |
|
D.V. Nebieridze (1), T.V. Kamyshova (1), A.A. Sarycheva (2)
EVALUATION OF FREQUENCY OF TARGET ORGAN DAMAGE IN PATIENTS WITH ARTERIAL HYPERTENSION WHO APPLIED FOR AN OUTPATIENT APPOINTMENT WITH A DOCTOR FOR THE FIRST TIME
|
43-47 |
|
I.O. Schederkina (1, 2), N.N. Zavadenko (1, 2), A.N. Zavadenko (2), I.E. Koltunov (2)
TREATMENT OF EPILEPSY IN OUTPATIENT PEDIATRIC NEUROLOGY: CURRENT APPROACHES TO PHARMACOTHERAPY
|
48-53 |
|
I.Yu Torshin (1), O.A. Gromova (2)
MOLECULAR FUNCTIONS OF MAGNESIUM-DEPENDENT MYOCARDIAL PROTEINS INDICATE PROSPECTS FOR USE OF MAGNESIUM OROTATE PREPARATIONS IN CARDIOLOGICAL PRACTICE
|
54-58 |
|
N.P. Lyamina, A.V. Nalivaeva
CARDIORENAL CONCEPT AND CURRENT POSITION OF NEPHROPROTECTION OF LERCANIDIPINE
|
60-64 |
|
A.S. Kadykov, N.V. Shakhparonova, E.M. Kashina
COGNITIVE IMPAIRMENT IN VASCULAR AND DEGENERATIVE BRAIN DISEASES: DIAGNOSIS AND TREATMENT
|
66-71 |
Русский
